<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<measures><measure><type>Main</type><parent-measure></parent-measure><title>Number of meetings to discuss Pre-Emergency Use Authorization (EUA) development in the month</title><dictionary>The emergency use authorization authority can only be used after the Secretary of Health and Human Services declares an emergency.  Pre-emergency activities completed by FDA will ensure regulatory issues are addressed before the emergency occurs, enabling a smooth process of distributing medical countermeasures to the public during an emergency.</dictionary><footnotes><note></note></footnotes><measure-description>Number of Meetings</measure-description><chart-type>column</chart-type><chart-color></chart-color><right-min></right-min><right-max></right-max><fiscal-year><chart-min></chart-min><chart-max></chart-max><title>2010</title><target-header></target-header><target-description></target-description><summary>FY 2010 6-Month Total: 14</summary><time><frame>Oct 2009</frame><target></target><value>N/A</value></time><time><frame>Nov 2009</frame><target></target><value>N/A</value></time><time><frame>Dec 2009</frame><target></target><value>N/A</value></time><time><frame>Jan 2010</frame><target></target><value>N/A</value></time><time><frame>Feb 2010</frame><target></target><value>N/A</value></time><time><frame>Mar 2010</frame><target></target><value>N/A</value></time><time><frame>Apr 2010</frame><target></target><value>3</value></time><time><frame>May 2010</frame><target></target><value>2</value></time><time><frame>Jun 2010</frame><target></target><value>0</value></time><time><frame>Jul 2010</frame><target></target><value>1</value></time><time><frame>Aug 2010</frame><target></target><value>6</value></time><time><frame>Sep 2010</frame><target></target><value>2</value></time></fiscal-year><fiscal-year><chart-min></chart-min><chart-max></chart-max><title>2011</title><target-header></target-header><target-description></target-description><summary>FY 2011 7-Month Total: 20</summary><time><frame>Oct 2010</frame><target></target><value>2</value></time><time><frame>Nov 2010</frame><target></target><value>4</value></time><time><frame>Dec 2010</frame><target></target><value>1</value></time><time><frame>Jan 2011</frame><target></target><value>2</value></time><time><frame>Feb 2011</frame><target></target><value>3</value></time><time><frame>Mar 2011</frame><target></target><value>4</value></time><time><frame>Apr 2011</frame><target></target><value>4</value></time><time><frame>May 2011</frame><target></target><value>N/A</value></time><time><frame>Jun 2011</frame><target></target><value>N/A</value></time><time><frame>Jul 2011</frame><target></target><value>N/A</value></time><time><frame>Aug 2011</frame><target></target><value>N/A</value></time><time><frame>Sep 2011</frame><target></target><value>N/A</value></time></fiscal-year></measure><related-links><link><url>http://www.fda.gov/AboutFDA/Transparency/track/ucm206688.htm</url><text>FDA-TRACK OC Office of the Chief Scientist Dashboard</text></link></related-links><glossary><word><text></text><definition></definition></word></glossary></measures>
    






